Pirfenidone CAS 53179-13-8 Kuchena ≥99.0% IPF

Tsanangudzo Pfupi:

Kemikari Zita: Pirfenidone

CAS: 53179-13-8

Kuchena: ≥99.0%

Kuonekwa: Kuchena kusvika kuChiedza Yero yeCrystalline Powder

High Quality, Commercial Production

Kurapa kweIdiopathic Pulmonary Fibrosis (IPF)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Supply With High Purity, Commercial Production
Kemikari Zita: Pirfenidone
CAS: 53179-13-8

Chemical Properties:

Chemical Name Pirfenidone
Mashoko anoreva zvakafanana Perfenidone;5-Methyl-1-Phenylpyridine-2(1H)-imwe;PFD;S-7701;AMR-69
Nhamba yeCAS 53179-13-8
Nhamba yeCAT RF-API108
Stock Status Mudura
Molecular Formula C12H11NO
Molecular Weight 185.22
Melting Point 96.0 kusvika 97.0 ℃
Solubility Soluble muDMSO
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Ichena kusvika kuChiedza Yero yeCrystalline Powder
Identification IR
Kuchena ≥99.0%
Kurasika paKuomesa ≤0.50%
Sulfated Ash ≤0.20%
Kusachena Kumwechete ≤0.50%
Zvose Zvisina Kuchena ≤1.0%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage API, Idiopathic Pulmonary Fibrosis (IPF)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

1

FAQ:

Application:

Pirfenidone (CAS: 53179-13-8) iri muboka remishonga inonzi antifibrotic agents.Pirfenidone yakaratidza kushanda mune dzakawanda fibrotic mamiriro, kusanganisira ayo emapapu, itsvo uye chiropa.Inokanganisa immune system yemuviri wako uye inoderedza huwandu hwefibrosis (mavanga) mumapapu.Pirfenidone mumwe wemishonga miviri inotenderwa muCanada kurapa Idiopathic Pulmonary Fibrosis (IPF).Pirfenidone inhibitor yeTGF-β kugadzirwa uye TGF-β yakakurudzira kugadzirwa kwecollagen, inoderedza kugadzirwa kweTNF-α uye IL-1β, uye inewo anti-fibrotic uye anti-inflammatory properties.Yakatanga kubvumirwa muJapan kurapwa kwevarwere vane idiopathic pulmonary fibrosis mushure mekuedzwa kwekliniki, pasi pezita rekutengeserana rePirespa naShionogi, muna 2008. Yakabvumirwa kushandiswa muEuropean Union muna 2011, muCanada mu2012, uye mu United States muna Gumiguru 2014.

Nyora meseji yako pano ugotitumira